Adam Balogh

TL;DR: Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures.

TL;DR: Treatment of postmenopausal women with osteoporosis with strontium ranelate results in a sustained reduction in the incidence of osteoporeotic nonvertebral fractures, including hip fractures, and vertebral fractures over 5 years.

TL;DR: It is suggested that calcium needed for fetal skeletal growth during pregnancy was gained from maternal trabecular and cortical sites and that calcium needs for infant growth during lactation was drawn mainly from the maternal trABecular skeleton in the authors' patients.

TL;DR: There is a high prevalence of hypovitaminosis D in healthy postmenopausal Hungarian women, and FN BMD is associated with serum 25-OH-D and dietary calcium intake, which was found to be significantly associated with age, the average hours of sunshine in the 3 months prior to 25- OH-D level determination and Dietary calcium intake.

TL;DR: The efficacy of raloxifene in reducing vertebral fractures is largely independent of the presence of clinical risk factors for osteoporotic fractures.